Quantitative proteomics of nasal mucus in chronic sinusitis with nasal polyposis

Yahya Al Badaai, Marcos R. DiFalco, Marc A. Tewfik, Mark Samaha

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Proteomics has been used as a tool for identification of the protein content of nasal mucus in diseased and healthy subjects. Thirty-five proteins in both chronic rhinosinusitis (CRS) and control groups were identified in a previous study by our group using conventional mass spectrometry analysis. Ten of these proteins were related to innate and acquired immunity and showed differences in expression between the two groups. Objective: To investigate the quantitative differential expression of specific nasal mucus proteins previously identified by our group using multiple reaction monitoring (MRM) mass spectrometry in patients with CRS with nasal polyposis compared with normal subjects. Methods: In a prospective case control study, nasal mucus from patients and control subjects was collected, desalted, resolubilized, and digested using proteolytic enzymes. Previously identified nasal mucus proteins with differential expression in CRS patients were targeted and quantitatively measured using MRM mass spectrometry. Results: Analysis of 12 samples (6 patients and 6 controls) identified 7 of the 10 targeted proteins, many of which were related to innate and acquired immunity. Quantitative analysis showed differential expression in CRS patients compared with control subjects. A detailed analysis and characterization of the protein isolates is outlined. Conclusion: This is the first proteomics study of nasal mucus in CRS with polyposis using the MRM technique. The findings suggest that innate and acquired immunity may play a role in the pathophysiology of CRS. Future steps in evaluating the protein characteristics of the mucus of CRS patients are aimed at developing biomarkers and potentially targeted therapies.

Original languageEnglish
Pages (from-to)381-389
Number of pages9
JournalJournal of Otolaryngology - Head and Neck Surgery
Volume38
Issue number3
DOIs
Publication statusPublished - Jun 2009

Fingerprint

Sinusitis
Mucus
Nose
Proteomics
Proteins
Adaptive Immunity
Innate Immunity
Mass Spectrometry
Case-Control Studies
Healthy Volunteers
Peptide Hydrolases
Biomarkers
Control Groups

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Surgery

Cite this

Quantitative proteomics of nasal mucus in chronic sinusitis with nasal polyposis. / Al Badaai, Yahya; DiFalco, Marcos R.; Tewfik, Marc A.; Samaha, Mark.

In: Journal of Otolaryngology - Head and Neck Surgery, Vol. 38, No. 3, 06.2009, p. 381-389.

Research output: Contribution to journalArticle

Al Badaai, Yahya ; DiFalco, Marcos R. ; Tewfik, Marc A. ; Samaha, Mark. / Quantitative proteomics of nasal mucus in chronic sinusitis with nasal polyposis. In: Journal of Otolaryngology - Head and Neck Surgery. 2009 ; Vol. 38, No. 3. pp. 381-389.
@article{c82c3ced02d449e1a48f6f182466c27c,
title = "Quantitative proteomics of nasal mucus in chronic sinusitis with nasal polyposis",
abstract = "Background: Proteomics has been used as a tool for identification of the protein content of nasal mucus in diseased and healthy subjects. Thirty-five proteins in both chronic rhinosinusitis (CRS) and control groups were identified in a previous study by our group using conventional mass spectrometry analysis. Ten of these proteins were related to innate and acquired immunity and showed differences in expression between the two groups. Objective: To investigate the quantitative differential expression of specific nasal mucus proteins previously identified by our group using multiple reaction monitoring (MRM) mass spectrometry in patients with CRS with nasal polyposis compared with normal subjects. Methods: In a prospective case control study, nasal mucus from patients and control subjects was collected, desalted, resolubilized, and digested using proteolytic enzymes. Previously identified nasal mucus proteins with differential expression in CRS patients were targeted and quantitatively measured using MRM mass spectrometry. Results: Analysis of 12 samples (6 patients and 6 controls) identified 7 of the 10 targeted proteins, many of which were related to innate and acquired immunity. Quantitative analysis showed differential expression in CRS patients compared with control subjects. A detailed analysis and characterization of the protein isolates is outlined. Conclusion: This is the first proteomics study of nasal mucus in CRS with polyposis using the MRM technique. The findings suggest that innate and acquired immunity may play a role in the pathophysiology of CRS. Future steps in evaluating the protein characteristics of the mucus of CRS patients are aimed at developing biomarkers and potentially targeted therapies.",
author = "{Al Badaai}, Yahya and DiFalco, {Marcos R.} and Tewfik, {Marc A.} and Mark Samaha",
year = "2009",
month = "6",
doi = "10.2310/7070.2009.080089",
language = "English",
volume = "38",
pages = "381--389",
journal = "Journal of Otolaryngology - Head and Neck Surgery",
issn = "1916-0208",
publisher = "Decker Publishing",
number = "3",

}

TY - JOUR

T1 - Quantitative proteomics of nasal mucus in chronic sinusitis with nasal polyposis

AU - Al Badaai, Yahya

AU - DiFalco, Marcos R.

AU - Tewfik, Marc A.

AU - Samaha, Mark

PY - 2009/6

Y1 - 2009/6

N2 - Background: Proteomics has been used as a tool for identification of the protein content of nasal mucus in diseased and healthy subjects. Thirty-five proteins in both chronic rhinosinusitis (CRS) and control groups were identified in a previous study by our group using conventional mass spectrometry analysis. Ten of these proteins were related to innate and acquired immunity and showed differences in expression between the two groups. Objective: To investigate the quantitative differential expression of specific nasal mucus proteins previously identified by our group using multiple reaction monitoring (MRM) mass spectrometry in patients with CRS with nasal polyposis compared with normal subjects. Methods: In a prospective case control study, nasal mucus from patients and control subjects was collected, desalted, resolubilized, and digested using proteolytic enzymes. Previously identified nasal mucus proteins with differential expression in CRS patients were targeted and quantitatively measured using MRM mass spectrometry. Results: Analysis of 12 samples (6 patients and 6 controls) identified 7 of the 10 targeted proteins, many of which were related to innate and acquired immunity. Quantitative analysis showed differential expression in CRS patients compared with control subjects. A detailed analysis and characterization of the protein isolates is outlined. Conclusion: This is the first proteomics study of nasal mucus in CRS with polyposis using the MRM technique. The findings suggest that innate and acquired immunity may play a role in the pathophysiology of CRS. Future steps in evaluating the protein characteristics of the mucus of CRS patients are aimed at developing biomarkers and potentially targeted therapies.

AB - Background: Proteomics has been used as a tool for identification of the protein content of nasal mucus in diseased and healthy subjects. Thirty-five proteins in both chronic rhinosinusitis (CRS) and control groups were identified in a previous study by our group using conventional mass spectrometry analysis. Ten of these proteins were related to innate and acquired immunity and showed differences in expression between the two groups. Objective: To investigate the quantitative differential expression of specific nasal mucus proteins previously identified by our group using multiple reaction monitoring (MRM) mass spectrometry in patients with CRS with nasal polyposis compared with normal subjects. Methods: In a prospective case control study, nasal mucus from patients and control subjects was collected, desalted, resolubilized, and digested using proteolytic enzymes. Previously identified nasal mucus proteins with differential expression in CRS patients were targeted and quantitatively measured using MRM mass spectrometry. Results: Analysis of 12 samples (6 patients and 6 controls) identified 7 of the 10 targeted proteins, many of which were related to innate and acquired immunity. Quantitative analysis showed differential expression in CRS patients compared with control subjects. A detailed analysis and characterization of the protein isolates is outlined. Conclusion: This is the first proteomics study of nasal mucus in CRS with polyposis using the MRM technique. The findings suggest that innate and acquired immunity may play a role in the pathophysiology of CRS. Future steps in evaluating the protein characteristics of the mucus of CRS patients are aimed at developing biomarkers and potentially targeted therapies.

UR - http://www.scopus.com/inward/record.url?scp=67049096216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67049096216&partnerID=8YFLogxK

U2 - 10.2310/7070.2009.080089

DO - 10.2310/7070.2009.080089

M3 - Article

VL - 38

SP - 381

EP - 389

JO - Journal of Otolaryngology - Head and Neck Surgery

JF - Journal of Otolaryngology - Head and Neck Surgery

SN - 1916-0208

IS - 3

ER -